Related Experiment Video
Updated: Nov 20, 2025

Improved Rodent Model of Myocardial Ischemia and Reperfusion Injury
Published on: March 7, 2022
Cellular mechanisms and pathways in myocardial reperfusion injury
Ioannis Valikeserlis1, Amaryllis-Aikaterini Athanasiou2, Dimitrios Stakos3
1Department of Internal Medicine, General Hospital of Chalkidiki, Polygyros.
Insights
Ischemia-reperfusion injury involves multiple cell types and molecular pathways, impacting heart attack recovery. Understanding these cellular and molecular mechanisms is key to improving patient outcomes and reducing mortality after myocardial infarction.
Area of Science:
- Cardiovascular Medicine
- Immunology
- Cell Biology
Background:
- Ischemia-reperfusion injury (IRI) significantly increases mortality and hospitalization post-myocardial infarction.
- The pathophysiology of IRI involves a complex interplay of various cell types and molecular pathways.
- Despite advancements, precise mechanisms for all contributing cells and pathways in IRI remain under investigation.
Purpose of the Study:
- To review the specific contributions of different cell types to IRI pathophysiology.
- To elucidate the molecular pathways involved in IRI.
- To provide a comprehensive understanding of IRI mechanisms for potential therapeutic targets.
Main Methods:
- Literature review focusing on cellular and molecular mechanisms of IRI.
- Synthesis of information on the roles of cardiomyocytes, fibroblasts, stromal cells, endothelial cells, platelets, immune cells (polymorphonuclear cells, macrophages, T lymphocytes).
- Analysis of key molecular mediators including toll-like receptors, inflammasomes, reactive oxygen species, calcium overload, and mitochondrial dysfunction.
Main Results:
- Endothelial dysfunction, immune activation, and inflammatory responses are critical in IRI.
- Cardiac fibroblasts and mesenchymal stromal cells initiate and propagate inflammation via inflammasome activation.
- Immune cells like polymorphonuclear cells and macrophages produce damaging reactive oxygen species and enzymes, while T cells modulate injury.
- Endothelial and platelet activation contribute to microcirculation dysfunction and immune cell recruitment.
Conclusions:
- IRI is a multifactorial process involving diverse cellular players and molecular signaling.
- Targeting specific cellular interactions and molecular pathways (e.g., inflammasomes, oxidative stress) may offer therapeutic strategies.
- Further research into the intricate mechanisms of IRI is essential for developing effective treatments to mitigate myocardial damage and improve recovery.
Abstract:
Despite the progress of cardiovascular medicine, ischemia-reperfusion injury can contribute to increased mortality and prolonged hospitalization after myocardial infarction. Ischemia-reperfusion injury pathophysiology encompasses many cells including cardiomyocytes, fibroblasts, mesenchymal stromal cells, vascular endothelial and smooth muscle cells, platelets, polymorphonuclear cells, macrophages, and T lymphocytes. However, specific mechanisms for all contributing cells and molecular pathways are still under investigation. What is definitely known is that endothelial dysfunction, immunity activation and inflammatory response are crucial events during ischemia-reperfusion injury while toll-like receptors, inflammasomes, reactive oxygen species, intracellular calcium overload and mitochondrial permeability transition pore opening consist of key molecular mediators. Indicatively, cardiac fibroblasts through inflammasome activation mediate the initial inflammatory response. Cardiac mesenchymal stromal cells can respond to myocardial injury by pro-inflammatory activation. Endothelial cell activation contributes to the impaired vasomotion, inflammation and thrombotic events and together with platelet activation leads to microcirculation dysfunction and polymorphonuclear cells recruitment promoting inflammation. Polymorphonuclear cells and monocytes/macrophages subsets are critically involved in the inflammation process by producing toxic proteolytic enzymes and reactive oxygen species. T cells subsets are also involved in several stages of ischemia-reperfusion injury. In this review, we summarize the specific contribution of each of the above cells and the related molecular pathways in the pathophysiology of ischemia-reperfusion injury.
Related Concept Videos
Myocarditis I: Introduction
Pathophysiology of Heart Failure
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...

